- The folks at Hoffmann-La Roche are studying Colorectal Cancer in individuals ages 18 years and older. This clinical trial is slated to start April 2013 and is expected to end circa August 2016.888-662-6728 (U.S. Only) Reference Study ID Number: ML28411 www.roche.com/about_roche/roche_worldwide.htm
|Recruiting||Reference Study ID Number: ML28411 email@example.com||888-662-6728 (U.S. Only)|
This study is officially titled, "Non-interventional Local Study to Describe the Safety, Tolerability and Efficacy of Bevacizumab in Combination With Standard Chemotherapy Regimens as First Line in Patients With Metastatic Cancer of the Colon or the Rectum."
Montenegro - map
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.